Published in PLoS One on March 12, 2012
Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice. J Nutr (2014) 0.84
Mitochondrial DNA damage induced autophagy, cell death, and disease. Front Biosci (Landmark Ed) (2016) 0.84
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations. Oncotarget (2015) 0.79
Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes. Front Physiol (2014) 0.77
The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting. Semin Cell Dev Biol (2015) 0.77
Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia. J Cachexia Sarcopenia Muscle (2015) 0.75
Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation. Oxid Med Cell Longev (2017) 0.75
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev (2008) 6.57
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Cachexia: a new definition. Clin Nutr (2008) 5.49
PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A (2006) 5.28
Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev (2008) 4.87
Retracted Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A (2009) 4.37
Cachexia in cancer patients. Nat Rev Cancer (2002) 3.63
PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ (2006) 2.88
Retracted Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab (2008) 2.80
Role of myokines in exercise and metabolism. J Appl Physiol (1985) (2007) 2.52
In vivo and in organello assessment of OXPHOS activities. Methods (2002) 2.34
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr (2006) 2.20
Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01
Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care (2005) 1.73
The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract (2005) 1.55
Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem (2011) 1.46
Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. J Support Oncol (2007) 1.33
Retracted Endurance exercise is protective for mice with mitochondrial myopathy. J Appl Physiol (1985) (2009) 1.29
Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia. Cancer Res (2000) 1.23
Muscle oxidative capacity during IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp Physiol (2010) 1.19
Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer (1993) 1.18
TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J (2010) 1.01
Metabolic abnormalities in cachexia and anorexia. Nutrition (2000) 0.93
Cancer cachexia. Mol Cancer (2003) 0.86
Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections. JPEN J Parenter Enteral Nutr (2001) 0.84
Peroxisome proliferator-activated receptors gamma coactivator-1alpha: master regulator of mitochondrial biogenesis and survival during critical illness? Am J Respir Crit Care Med (2010) 0.78
Retracted Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A (2009) 4.37
Inadequate anaesthesia in lethal injection for execution. Lancet (2005) 3.98
The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol (2007) 3.47
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer (2012) 3.12
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature (2012) 3.09
Retracted Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab (2008) 2.80
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol Cell (2004) 2.61
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
Can lethal injection for execution really be "fixed"? Lancet (2007) 2.33
Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol (2002) 1.97
Pattern of organization of human mitochondrial pseudogenes in the nuclear genome. Genome Res (2002) 1.87
Regulation of muscle mass by follistatin and activins. Mol Endocrinol (2010) 1.79
Liver regeneration. J Am Coll Surg (2003) 1.79
Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet (2010) 1.78
Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum Mol Genet (2005) 1.77
The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci (2008) 1.65
Cytochrome c oxidase is required for the assembly/stability of respiratory complex I in mouse fibroblasts. Mol Cell Biol (2006) 1.64
Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons. Hum Mol Genet (2008) 1.62
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med (2013) 1.61
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans. Hum Mol Genet (2005) 1.56
Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc Natl Acad Sci U S A (2005) 1.54
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood (2012) 1.53
Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J Neurosci (2005) 1.50
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2007) 1.47
Human mitochondrial DNA with large deletions repopulates organelles faster than full-length genomes under relaxed copy number control. Nucleic Acids Res (2002) 1.47
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun (2009) 1.45
Retracted mTERF2 regulates oxidative phosphorylation by modulating mtDNA transcription. Cell Metab (2009) 1.31
Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol (2003) 1.29
Retracted Endurance exercise is protective for mice with mitochondrial myopathy. J Appl Physiol (1985) (2009) 1.29
Heterologous mitochondrial DNA recombination in human cells. Hum Mol Genet (2004) 1.23
Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology (2007) 1.20
Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget (2012) 1.20
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19
Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut (2008) 1.16
The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimers. Cell Metab (2010) 1.16
PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum Mol Genet (2009) 1.14
The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci (2011) 1.14
Intra- and inter-molecular recombination of mitochondrial DNA after in vivo induction of multiple double-strand breaks. Nucleic Acids Res (2009) 1.13
A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions. Hum Mol Genet (2012) 1.13
In vivo methylation of mtDNA reveals the dynamics of protein-mtDNA interactions. Nucleic Acids Res (2009) 1.10
Cells lacking Rieske iron-sulfur protein have a reactive oxygen species-associated decrease in respiratory complexes I and IV. Mol Cell Biol (2011) 1.10
Mitochondrial biogenesis and turnover. Cell Calcium (2008) 1.10
Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease. J Neurosci (2011) 1.09
A chemical enucleation method for the transfer of mitochondrial DNA to rho(o) cells. Nucleic Acids Res (2003) 1.08
PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Hum Mol Genet (2007) 1.07
Body surface area prediction in normal, hypermuscular, and obese mice. J Surg Res (2008) 1.07
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res (2011) 1.06
Transcriptional co-expression and co-regulation of genes coding for components of the oxidative phosphorylation system. BMC Genomics (2008) 1.05
Somatic mtDNA mutation spectra in the aging human putamen. PLoS Genet (2013) 1.04
Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. Hum Mol Genet (2012) 1.02
Limitations of allotopic expression of mitochondrial genes in mammalian cells. Genetics (2003) 1.02
Mitochondrial disorders caused by mutations in respiratory chain assembly factors. Semin Fetal Neonatal Med (2011) 1.02
Loss of Mcl-1 protein and inhibition of electron transport chain together induce anoxic cell death. Mol Cell Biol (2006) 1.02
Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates. Hum Mol Genet (2007) 1.01
Oxidative phosphorylation dysfunction modulates expression of extracellular matrix--remodeling genes and invasion. Carcinogenesis (2005) 1.01
Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood (2013) 1.01
Transmitochondrial technology in animal cells. Methods Cell Biol (2007) 1.01
Mitochondrial DNA transcription regulation and nucleoid organization. J Inherit Metab Dis (2011) 1.00
Scientific impact of women in academic surgery. J Surg Res (2008) 1.00
The role of PGC-1 coactivators in aging skeletal muscle and heart. IUBMB Life (2012) 1.00
Lack of cytochrome c in mouse fibroblasts disrupts assembly/stability of respiratory complexes I and IV. J Biol Chem (2008) 0.98
Perspective: PhD scientists completing medical school in two years: looking at the Miami PhD-to-MD program alumni twenty years later. Acad Med (2010) 0.97
Hedgehog signaling regulates bladder cancer growth and tumorigenicity. Cancer Res (2012) 0.97
Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia. J Cachexia Sarcopenia Muscle (2012) 0.97
Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release. Mol Cell Biol (2007) 0.97
An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment. J Neurochem (2004) 0.96
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression. Proc Natl Acad Sci U S A (2013) 0.96
BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA. J Biol Chem (2002) 0.95
Fast adaptive coevolution of nuclear and mitochondrial subunits of ATP synthetase in orangutan. Mol Biol Evol (2004) 0.93
Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases. Biochim Biophys Acta (2008) 0.90
Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury. J Neurotrauma (2008) 0.90
Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels. Mol Oncol (2011) 0.90
Decreased mitochondrial tRNALys steady-state levels and aminoacylation are associated with the pathogenic G8313A mitochondrial DNA mutation. Biochem J (2003) 0.89
Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target? Mol Neurobiol (2006) 0.89
Mitochondrial transcription: lessons from mouse models. Biochim Biophys Acta (2011) 0.88
Superoxide released into the mitochondrial matrix. Free Radic Biol Med (2006) 0.86
Overexpression of Twinkle-helicase protects cardiomyocytes from genotoxic stress caused by reactive oxygen species. Proc Natl Acad Sci U S A (2013) 0.86
A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations. J Cell Mol Med (2011) 0.86
Emerging therapeutic approaches to mitochondrial diseases. Dev Disabil Res Rev (2010) 0.86
Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage. Hum Mol Genet (2013) 0.85
The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation. J Bioenerg Biomembr (2009) 0.85
Resolving the role of IL-6 in liver regeneration. Hepatology (2003) 0.83
Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy. Mitochondrion (2012) 0.82
A comprehensive evaluation of outcomes for inflammatory breast cancer. Breast Cancer Res Treat (2009) 0.82
Mouse models of oxidative phosphorylation dysfunction and disease. Methods (2008) 0.82
Nitric oxide synthesis is increased in cybrid cells with m.3243A>G mutation. Int J Mol Sci (2012) 0.82
COX2-derived primary and cyclopentenone prostaglandins are increased after asphyxial cardiac arrest. Brain Res (2013) 0.82
SUS/AAS abstracts: what is the scientific impact? Surgery (2008) 0.82
Transient systemic mtDNA damage leads to muscle wasting by reducing the satellite cell pool. Hum Mol Genet (2013) 0.82
Mouse models of Parkinson's disease associated with mitochondrial dysfunction. Mol Cell Neurosci (2012) 0.81
Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse. PLoS One (2012) 0.81
Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments. Adv Cancer Res (2013) 0.80
Regional susceptibilities to mitochondrial dysfunctions in the CNS. Biol Chem (2012) 0.80
Systematic association studies of mitochondrial DNA variations in schizophrenia: focus on the ND5 gene. Schizophr Bull (2007) 0.80